TripSitter Clinic Ltd.
KETA.CN
Canadian Securities Exchange0.16
CAD
+0.03
- -
TripSitter Clinic Ltd.
KETA.CN
(Canadian Securities Exchange)
Recent
price
0.16
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- TripSitter Clinic Ltd. (CSE: KETA) operates a consultative virtual clinic and telehealth platform focused on mental health treatment incorporating legal psychedelic medicine, primarily therapeutic low-dose ketamine; the company's SaaS-based TripSitter.Clinic connects patients with licensed physicians in the United States for evaluation, prescription, care, monitoring, coaching, and coordination with primary care providers and experts, requiring patients to submit a prior PCP diagnosis during intake. Founded in 2021 through the amalgamation of its wholly-owned subsidiary Tripsitter Clinic Corp. (incorporated October 2020) with predecessor entities, TripSitter maintains headquarters in Vancouver, British Columbia, Canada, and delivers services across 23 U.S. states including Arizona, California, Colorado, Florida, Georgia, Illinois, Iowa, Kentucky, Maine, Michigan, Minnesota, Mississippi, Montana, Nebraska, New Hampshire, North Dakota, Oklahoma, Tennessee, Vermont, Washington, West Virginia, Wisconsin, and Wyoming; the platform functions as a mobile-first web app emphasizing safety protocols for psychedelic-assisted therapy without serving as a primary care physician. In recent developments, the company completed the Reconscious Asset Acquisition on January 31, 2023, acquiring core assets from Insight Systems PBC d.b.a. Reconscious Medical—a psychedelic psychotherapy provider offering in-clinic and virtual care with ketamine dosing—for 1 million common shares and 1 million warrants, alongside settling US$76,244.93 in debt via 2 million shares and 1 million warrants; further changes include a 1-for-5 share consolidation on August 30, 2023 reducing outstanding shares to 6.66 million, dissolution of U.S. subsidiary Tripsitter Corp. on September 27, 2023 with plans for a Nevada replacement, termination of its prior telehealth provider prompting a search for a new partner to resume patient intakes, multiple promissory note issuances to related party Cabazon Capital Ltd. totaling $293,140 by January 2024 at 12% interest, and ongoing efforts to manage liquidity amid declining revenue to $13,975 for fiscal 2024 from $488,301 in 2023 while incurring net losses and a $727,740 working capital deficit.